Dr. Karan Surinder Bhalla, MD

Dr. Bhalla practices at Houston Plastic and Craniofacial Surgery Center in Houston, Texas.

Dr. Bhalla's NPI, 1407902794, was assigned on January 27, 2007. Dr. Bhalla holds Texas license M3160.

Dr. Bhalla's primary practice is Houston Plastic and Craniofacial Surgery Center, at 6400 Fannin St, Houston, TX 77030 in Harris County. The practice phone is (713) 791-0700.

Dr. Bhalla's primary practice is Houston Plastic and Craniofacial Surgery Center in Houston, Texas. Dr. Bhalla is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Houston Cardiovascular Associates. Dmand AI also links Dr. Bhalla to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhalla practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bhalla's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bhalla is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bhalla's licenses on file in 2 states: Texas and Alabama.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Bhalla treats.

CMS data shows 10,960 Medicare services from Dr. Bhalla across 43 procedure codes in 2024, for 727 Medicare patients. Medicare paid $2,142,040 for them.

CMS counts 727 Medicare patients who saw Dr. Bhalla in 2024. The largest group is 65 to 74, with 366 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhalla's median patient age at 69, with 48% women.

In 2024, Dr. Bhalla wrote 7,803 Medicare Part D claims for 1,196 patients. 85% of them were for generic drugs. CMS names the drug for 7,401 of them, across 64 drugs with 11 or more claims each, at $1,398,187 in total drug cost. In 2023, CMS named 6,511 claims across 57 drugs.

Dr. Bhalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhalla as offering telehealth. CMS counts 119 procedures of varicose vein removal by Dr. Bhalla, more than 86% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Bhalla in 2022. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Bone Marrow Transplantation and Breast Neoplasms. Dr. Bhalla has published most often in Am J Respir Crit Care Med. Dr. Bhalla's most frequent co-author is Rodney J. Folz, MD, PhD.

Dmand AI links Dr. Bhalla to 3 clinical trials. Conditions studied include Atrial Fibrillation, Arrhythmias, Cardiac and Peripheral Arterial Disease. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 1,100 general payments to Dr. Bhalla from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Boston Scientific Corporation paid the most, $30,805. It also lists 10 research payments totaling $27,400 from 2019 to 2020.

Dr. Bhalla is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.